Pharmafile Logo

toothbrush

- PMLiVE

Why a LinkedIn short video feed is so exciting for healthcare comms

LinkedIn has confirmed that it’s currently experimenting with a short video feed, TikTok-style. This has rather split opinion online, with some seeing it as a mix that won’t work, while...

Wallace Health

- PMLiVE

Reaching Women Where They’re At: Setting Up a Safe Space for HIV Prevention Conversations

“I always enjoyed solving problems and putting puzzles together,” says Harmony Garges, MD, CMO at ViiV Healthcare and a pediatric infectious disease specialist. “So for me, infectious disease was a...

Medscape Education

- PMLiVE

The MM+M Agency 100 report: Oxford PharmaGenesis is recognized as an industry leader for the fourth year running

For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the...

Oxford PharmaGenesis

- PMLiVE

AstraZeneca’s Tagrisso combination approved by EC as first-line lung cancer treatment

Non-small cell lung cancer accounts for up to 85% of all lung cancer diagnoses

- PMLiVE

J&J’s multidrug-resistant TB treatment Sirturo granted full EC and FDA approvals

An estimated 410,000 people globally developed multidrug- or rifampicin-resistant TB in 2022

- PMLiVE

LEO Pharma, Allergy UK and CHE Taskforce survey reveals burden of chronic hand eczema

The painful inflammatory skin condition, hand eczema, affects up to 14% of the UK population

- PMLiVE

Study identifies thousands of high-risk cancer gene variants and potential therapeutic target

Patients with inherited variants of the BAP1 gene have a 50% increased risk of developing certain cancers

- PMLiVE

Amgen’s Uplizna shown to improve pain and quality of life in attack-free NMOSD patients

The rare autoimmune disease is estimated to affect approximately 6,000 adults in the US

- PMLiVE

Emotive announces brand evolution

The agency’s refreshed visual identity has been launched alongside a new website

- PMLiVE

Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference

Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...

Medscape Education

- PMLiVE

Sanofi’s investigational frexalimab shows promise in relapsing MS study

Approximately 2.9 million people worldwide are affected by the neurological disease

- PMLiVE

Celebrating the 2024 Communiqué Awards

The event, now in its 26th year, has become a calendar staple in the healthcare and medcomms industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links